HM
HAE icon

HealthCor Management’s Haemonetics HAE Stock Holding History

HealthCor Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-148,480
Closed -$16.5M – 88
2021
Q1 		$16.5M Sell
148,480
-417,890
-74% -$51.7M 0.58% 46
2020
Q4 		$67.3M Buy
+566,370
New +$61M 2.59% 19
2020
Q2 		– Sell
-1,438,356
Closed -$143M – 57
2020
Q1 		$143M Buy
1,438,356
+899,394
+167% +$97.5M 6.13% 2
2019
Q4 		$61.9M Buy
538,962
+327,292
+155% +$39.6M 2.21% 16
2019
Q3 		$26.7M Sell
211,670
-138,520
-40% -$17.6M 1.01% 34
2019
Q2 		$42.1M Sell
350,190
-1,007,220
-74% -$99.1M 1.64% 25
2019
Q1 		$119M Buy
1,357,410
+257,270
+23% +$23.4M 4.8% 6
2018
Q4 		$110M Buy
1,100,140
+800,901
+268% +$84.1M 3.44% 11
2018
Q3 		$34.3M Buy
+299,239
New +$31M 1.14% 30
2018
Q2 		– Sell
-497,410
Closed -$36.4M – 58
2018
Q1 		$36.4M Sell
497,410
-952,590
-66% -$65.4M 1.24% 29
2017
Q4 		$84.2M Sell
1,450,000
-2,343
-0.2% -$123K 2.74% 14
2017
Q3 		$65.2M Sell
1,452,343
-402,529
-22% -$16.7M 2.18% 18
2017
Q2 		$73.2M Buy
1,854,872
+254,872
+16% +$10.5M 2.64% 14
2017
Q1 		$64.9M Buy
1,600,000
+450,000
+39% +$17.6M 2.98% 11
2016
Q4 		$46.2M Buy
+1,150,000
New +$43.4M 2.61% 16

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

HealthCor Management's HAE Position: Q2 2021 in Review

HealthCor Management sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 148,480 shares — an estimated $16.5M sold.

HealthCor Management first reported a position in HAE in Q4 2016 and held it in 15 quarters. The position peaked at $143M in Q1 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • HealthCor Management reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
  • HealthCor Management sold 148,480 Haemonetics shares in Q2 2021, an estimated $16.5M.
  • HealthCor Management first reported a position in Haemonetics in Q4 2016 and held it in 15 quarters.
  • HealthCor Management's Haemonetics position peaked at $143M in Q1 2020.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on HealthCor Management's 13F filing for Q2 2021, filed 16 Aug 2021.